Profile
Danny Robert Hegglin served as a Non-Executive Director at Realm Therapeutics Plc from 2013 to 2017 and as a Partner at TT International (Hong Kong) Ltd.
from 2009 to 2013.
Former positions of Danny Robert Hegglin
| Companies | Position | End |
|---|---|---|
| REALM THERAPEUTICS PLC | Director/Board Member | 2017-11-16 |
TT International (Hong Kong) Ltd.
 TT International (Hong Kong) Ltd. Investment ManagersFinance TT International (Hong Kong) Ltd. (TT-Hong Kong) is the alternative investment management subsidiary of Great Britain-based TT International Asset Management Ltd., which was acquired in 2020 by Sumitomo Mitsui Financial Group, Inc. (TYO: 8316) in Japan. Headquartered in Hong Kong, TT-Hong Kong was founded in 2004 to manage long/short Asian equities and hedge fund products, primarily for sophisticated institutional investors. | President | 2012-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
TT International (Hong Kong) Ltd.
TT International (Hong Kong) Ltd. Investment ManagersFinance TT International (Hong Kong) Ltd. (TT-Hong Kong) is the alternative investment management subsidiary of Great Britain-based TT International Asset Management Ltd., which was acquired in 2020 by Sumitomo Mitsui Financial Group, Inc. (TYO: 8316) in Japan. Headquartered in Hong Kong, TT-Hong Kong was founded in 2004 to manage long/short Asian equities and hedge fund products, primarily for sophisticated institutional investors. | Finance |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
- Stock Market
- Insiders
- Danny Robert Hegglin
